SciVision Biotech Inc.

NT$47.05As of Sun 8 Nov 2026, 12:00 UTC
TWSE:1786Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 2.76%
Div yield 4.06%
ROE 7.69%
Medical Instruments & Supplies
Beta (5Y) 0.43
PE TTM 24.77
TSR TTM (46.01%)
Mkt cap NT$3.521B
ROIC 8.46%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$60
27.26%
87.56%
Hold 0|7|3|4|8
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.87
0.90
0.94
0.93
(0.46%)
(5.76%)
3.84%
4.32%
RevenueNT$M
362.0
369.8
366.7
361.0
10.60%
10.37%
7.70%
5.63%
Peers (US$106.3M)
Cap (US$)
PE
107.4M
38.25x
94.01M
10.78x
108.6M
9.067x
Capital
TTM
5Y
10Y
Leveragex
0.878
0.012
0.012
EBIT/Intx
1.343
0.587
0.603
Own earn%
36.90
(7.79)
24.06
Sh yield%
26.40
8.19
13.94
Owners
Insiders/Inst%
9.43
81.87
Short interest%
4.69
SBC / revenue%
0.84
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
24–31
$1 testx
—
Incr. ROIC%
14